Genetically engineered worms that can't get drunk could lead to a 'James Bond' sobriety pill

Although creating drugs to help alcoholics would be far more useful

James Vincent
Wednesday 16 July 2014 10:34
Comments

Neuroscientists from the University of Texas have used genetic engineering to create worms incapable of getting drunk no matter how much alcohol they ingest.

The research, published in the Journal of Neuroscience this week, could be used to create drugs that treat the symptoms of alcohol withdrawal and perhaps one day block intoxication altogether in humans.

The key to the work stems from the scientists' modification of a “human alcohol target” that was implanted into a species of roundworm known as Caenorhabditis elegans. Human alcohol targets (of which there many) are molecular channels that bind alcohol in the body, triggering the whole spectrum of drunken behaviour.

For nematode worms (as for humans) this includes not being able to move as smoothly as when sober and giving up on procreation - two behavioural changes that make it easy for scientists to figure out when worms are drunk.

The researchers found that when creatures with the altered gene were dropped into petri dishes containing alcohol they simply did not display this behaviour – they just weren’t ‘getting drunk’.

An illustration from the research showing a sober and an intoxicated worm side by side.

"This is the first example of altering a human alcohol target to prevent intoxication in an animal," said research author Jon Pierce-Shimomura in a press release. "We got pretty lucky and found a way to make the channel insensitive to alcohol without affecting its normal function."

This last point is key as the molecular channel that the researchers modified (known as the BK channel SLO-1) also plays an important role elsewhere in the body, regulating the activity of neurons, blood vessels, the respiratory tract and the bladder.

Unlike other drugs such as cocaine, alcohol doesn’t have a single, specific target in the brain and instead hits a number of channels – a mechanism that causes the broad and complex effects of intoxication and alcohol addiction.

"Our findings provide exciting evidence that future pharmaceuticals might aim at this portion of the alcohol target to prevent problems in alcohol abuse disorders," says Pierce-Shimomura. "However, it remains to be seen which aspects of these disorders would benefit."

The researchers even speculated that one day they might be able to develop a “James Bond” drug that would enable spies to drink without becoming intoxicated - although its use outside of spycraft would be uncertain; if drinkers couldn't feel the effects of alcohol they might never stop.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in